DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE was reported 527 times

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UTERINE IRRITABILITY 1 0.0769
1 HIP DISARTICULATION 1 0.0625
2 FIBRONECTIN INCREASED 1 0.0556
3 PENOSCROTAL FUSION 1 0.0286
4 ACQUIRED PLAGIOCEPHALY 1 0.0270
5 MENINGOCELE 4 0.0255
6 HYDROCELE OPERATION 1 0.0233
7 SECONDARY HYPERTHYROIDISM 2 0.0206
8 SHORTENED CERVIX 6 0.0205
9 PLACENTA PRAEVIA HAEMORRHAGE 2 0.0182
10 UMBILICAL CORD SHORT 1 0.0175
11 MOEBIUS II SYNDROME 1 0.0159
12 CONGENITAL JOINT MALFORMATION 1 0.0159
13 SHONE COMPLEX 1 0.0147
14 OCULOAURICULOVERTEBRAL DYSPLASIA 1 0.0139
15 DELAYED SLEEP PHASE 1 0.0122
16 CONGENITAL SPINAL CORD ANOMALY 1 0.0119
17 TRANSVERSE PRESENTATION 1 0.0110
18 CONGENITAL TORTICOLLIS 1 0.0110
19 UTERINE CONTRACTIONS DURING PREGNANCY 10 0.0097
20 FOETAL MALPRESENTATION 1 0.0093
21 MORNING SICKNESS 5 0.0092
22 UMBILICAL CORD PROLAPSE 1 0.0081
23 DACRYOSTENOSIS CONGENITAL 1 0.0079
24 PRETERM PREMATURE RUPTURE OF MEMBRANES 9 0.0075
25 HYPERVITAMINOSIS 1 0.0072
26 UTERINE TACHYSYSTOLE 1 0.0069
27 TREMOR NEONATAL 3 0.0067
28 AMNIOCENTESIS ABNORMAL 1 0.0064
29 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
30 CERVICAL INCOMPETENCE 3 0.0059
31 RETROPLACENTAL HAEMATOMA 1 0.0058
32 TOOTH HYPOPLASIA 1 0.0057
33 SUBCHORIONIC HAEMATOMA 1 0.0057
34 PICA 1 0.0056
35 FOETAL HEART RATE ABNORMAL 5 0.0054
36 CONGENITAL AORTIC ANOMALY 1 0.0053
37 CERVIX HAEMORRHAGE UTERINE 1 0.0052
38 HYPEREMESIS GRAVIDARUM 2 0.0052
39 FAILED INDUCTION OF LABOUR 1 0.0052
40 URINE ALCOHOL TEST POSITIVE 1 0.0051
41 STRESS ULCER 1 0.0051
42 PECTUS EXCAVATUM 1 0.0049
43 PERIPHERAL NERVE OPERATION 1 0.0046
44 MATERNAL CONDITION AFFECTING FOETUS 1 0.0045
45 PERINATAL DEPRESSION 2 0.0044
46 CONGENITAL HEART VALVE DISORDER 1 0.0042
47 AMNIOTIC CAVITY INFECTION 3 0.0041
48 BREECH PRESENTATION 5 0.0040
49 PLACENTA PRAEVIA 3 0.0038
50 CONGENITAL EYE DISORDER 1 0.0037
51 FOETAL ARRHYTHMIA 1 0.0037
52 VENTILATION PERFUSION MISMATCH 1 0.0036
53 AUTOIMMUNE NEUTROPENIA 1 0.0035
54 BICUSPID AORTIC VALVE 2 0.0034
55 INDUCED LABOUR 2 0.0034
56 EXTENSOR PLANTAR RESPONSE 3 0.0033
57 DRUG SCREEN FALSE POSITIVE 9 0.0032
58 DELIVERY 2 0.0030
59 DRUG THERAPY 1 0.0029
60 PREMATURE DELIVERY 47 0.0029
61 PRE-ECLAMPSIA 14 0.0029
62 NEONATAL INFECTION 1 0.0029
63 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
64 VOMITING IN PREGNANCY 1 0.0028
65 TRISOMY 18 1 0.0026
66 REACTION TO COLOURING 1 0.0024
67 OCULOGYRIC CRISIS 5 0.0023
68 INCISIONAL DRAINAGE 1 0.0023
69 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
70 OPIATES POSITIVE 1 0.0021
71 COARCTATION OF THE AORTA 2 0.0021
72 SUDDEN INFANT DEATH SYNDROME 1 0.0020
73 VOCAL CORD DYSFUNCTION 1 0.0020
74 EXPOSURE VIA PARTNER 1 0.0020
75 PREMATURE LABOUR 11 0.0019
76 MILK-ALKALI SYNDROME 1 0.0019
77 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
78 MILK ALLERGY 1 0.0018
79 CLEFT LIP AND PALATE 2 0.0018
80 POLYDACTYLY 2 0.0017
81 HELLP SYNDROME 1 0.0016
82 TRISOMY 21 2 0.0016
83 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
84 CONGENITAL HAND MALFORMATION 1 0.0015
85 FOETAL HYPOKINESIA 1 0.0014
86 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
87 CARDIAC SEPTAL DEFECT 1 0.0014
88 CERVIX DISORDER 1 0.0014
89 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
90 COCCYDYNIA 2 0.0014
91 SUPPRESSED LACTATION 1 0.0013
92 VEIN COLLAPSE 1 0.0013
93 PREMATURE SEPARATION OF PLACENTA 2 0.0013
94 BREAST FEEDING 1 0.0013
95 BACTERIAL VAGINOSIS 2 0.0013
96 GESTATIONAL DIABETES 6 0.0013
97 PNEUMONIA MYCOPLASMAL 1 0.0013
98 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
99 VASCULAR ACCESS COMPLICATION 1 0.0012
100 NEONATAL HYPOXIA 1 0.0012
101 HYDROTHORAX 1 0.0012
102 FOETAL DISORDER 1 0.0012
103 CONGENITAL CARDIOVASCULAR ANOMALY 1 0.0012
104 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
105 CRANIOSYNOSTOSIS 1 0.0012
106 HEART DISEASE CONGENITAL 4 0.0011
107 CLONUS 3 0.0011
108 ADVERSE FOOD REACTION 1 0.0011
109 SLEEP-RELATED EATING DISORDER 1 0.0011
110 JAUNDICE NEONATAL 2 0.0011
111 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
112 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
113 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
114 AXILLARY MASS 1 0.0010
115 THYROID HORMONES INCREASED 1 0.0010
116 FOETAL DISTRESS SYNDROME 2 0.0009
117 HYDROCELE 1 0.0009
118 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
119 EXPOSURE DURING BREAST FEEDING 3 0.0009
120 HYPERREFLEXIA 3 0.0009
121 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
122 FEBRILE CONVULSION 1 0.0008
123 GESTATIONAL HYPERTENSION 1 0.0008
124 EXPOSURE DURING PREGNANCY 46 0.0007
125 MIGRAINE WITH AURA 2 0.0007
126 NORMAL NEWBORN 4 0.0007
127 DEATH NEONATAL 1 0.0007
128 MATERNAL EXPOSURE DURING PREGNANCY 63 0.0007
129 NAIL INFECTION 1 0.0007
130 CAESAREAN SECTION 8 0.0007
131 CONJUNCTIVITIS ALLERGIC 1 0.0007
132 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
133 CONGENITAL ANOMALY 5 0.0006
134 OPHTHALMOPLEGIA 1 0.0006
135 NEONATAL DISORDER 1 0.0006
136 ABORTION SPONTANEOUS 25 0.0006
137 METABOLIC ALKALOSIS 1 0.0006
138 RESPIRATORY DISORDER NEONATAL 1 0.0006
139 BRADYARRHYTHMIA 1 0.0006
140 LIVE BIRTH 5 0.0006
141 LAZINESS 1 0.0006
142 FOETAL DEATH 3 0.0006
143 HANGOVER 2 0.0006
144 BRONCHIOLITIS 2 0.0006
145 UTERINE SPASM 1 0.0005
146 AUTISM SPECTRUM DISORDER 3 0.0005
147 REBOUND EFFECT 6 0.0005
148 HYPERTONIA 3 0.0005
149 SEROTONIN SYNDROME 10 0.0005
150 LOW BIRTH WEIGHT BABY 4 0.0005
151 REBOUND ATOPIC DERMATITIS 1 0.0005
152 FOETAL GROWTH RESTRICTION 3 0.0005
153 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
154 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
155 PHYSICAL ASSAULT 1 0.0005
156 EYE CONTUSION 1 0.0005
157 EAR SWELLING 1 0.0005
158 TENSION HEADACHE 2 0.0005
159 HYPERPHOSPHATAEMIA 1 0.0005
160 INFUSION SITE BRUISING 1 0.0005
161 PREGNANCY 9 0.0004
162 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
163 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
164 REACTION TO EXCIPIENT 1 0.0004
165 HAEMANGIOMA 1 0.0004
166 PHARYNGEAL SWELLING 4 0.0004
167 INJECTION SITE ABSCESS 1 0.0004
168 VARICOSE VEIN 2 0.0004
169 PREGNANCY ON ORAL CONTRACEPTIVE 1 0.0004
170 YAWNING 1 0.0004
171 AKATHISIA 5 0.0004
172 JOINT LOCK 1 0.0004
173 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
174 PULMONARY PAIN 1 0.0003
175 STRABISMUS 1 0.0003
176 PREMATURE BABY 10 0.0003
177 EMERGENCY CARE 1 0.0003
178 EMBOLISM VENOUS 1 0.0003
179 DIASTOLIC DYSFUNCTION 1 0.0003
180 POSTURE ABNORMAL 1 0.0003
181 INFUSION SITE HAEMORRHAGE 1 0.0003
182 REGURGITATION 1 0.0003
183 HYPERTRANSAMINASAEMIA 2 0.0003
184 SINUS TACHYCARDIA 4 0.0003
185 SKIN WEEPING 1 0.0003
186 FEELING DRUNK 2 0.0003
187 INSURANCE ISSUE 4 0.0003
188 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
189 EXPOSURE VIA BREAST MILK 1 0.0003
190 PRODUCT ADMINISTRATION ERROR 5 0.0002
191 MUSCLE SPASTICITY 3 0.0002
192 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
193 MUSCLE FATIGUE 1 0.0002
194 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
195 VULVOVAGINAL DISCOMFORT 1 0.0002
196 RHINITIS ALLERGIC 1 0.0002
197 DEVELOPMENTAL DELAY 2 0.0002
198 DRUG EFFECT DELAYED 1 0.0002
199 HAEMOGLOBIN INCREASED 1 0.0002
200 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
201 EAR DISORDER 1 0.0002
202 PREGNANCY WITH IMPLANT CONTRACEPTIVE 1 0.0002
203 VAGINAL INFECTION 1 0.0002
204 SOMNOLENCE 42 0.0002
205 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
206 SMALL FOR DATES BABY 1 0.0002
207 APPLICATION SITE SWELLING 1 0.0002
208 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
209 DRY THROAT 2 0.0002
210 DRUG DISPENSING ERROR 3 0.0002
211 EUPHORIC MOOD 2 0.0002
212 APLASTIC ANAEMIA 1 0.0002
213 UNINTENDED PREGNANCY 2 0.0002
214 ANAL FISTULA 1 0.0002
215 ANAL ABSCESS 1 0.0002
216 BEHAVIOUR DISORDER 1 0.0002
217 INJECTION SITE NODULE 2 0.0002
218 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
219 STREPTOCOCCAL INFECTION 1 0.0002
220 IMPAIRED DRIVING ABILITY 2 0.0002
221 HERPES VIRUS INFECTION 1 0.0002
222 NIGHTMARE 6 0.0002
223 EYELID OEDEMA 2 0.0002
224 URINE ODOUR ABNORMAL 1 0.0002
225 MIGRAINE 16 0.0002
226 VAGINAL HAEMORRHAGE 7 0.0002
227 THERAPEUTIC RESPONSE CHANGED 1 0.0002
228 APPLICATION SITE VESICLES 1 0.0002
229 POST-TRAUMATIC STRESS DISORDER 1 0.0001
230 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
231 RESPIRATION ABNORMAL 1 0.0001
232 IMPAIRED WORK ABILITY 3 0.0001
233 VISUAL FIELD DEFECT 1 0.0001
234 TONGUE DISORDER 1 0.0001
235 INTENTIONAL UNDERDOSE 1 0.0001
236 MAJOR DEPRESSION 1 0.0001
237 HYPOPHOSPHATAEMIA 1 0.0001
238 MEDICAL DEVICE COMPLICATION 1 0.0001
239 CONCUSSION 1 0.0001
240 DRUG SCREEN POSITIVE 1 0.0001
241 RHINITIS 1 0.0001
242 FRUSTRATION TOLERANCE DECREASED 1 0.0001
243 POST PROCEDURAL INFECTION 1 0.0001
244 SENSATION OF FOREIGN BODY 1 0.0001
245 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
246 RASH GENERALISED 3 0.0001
247 WRONG DRUG ADMINISTERED 1 0.0001
248 PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0001
249 LOSS OF LIBIDO 1 0.0001
250 FREQUENT BOWEL MOVEMENTS 3 0.0001
251 GASTROENTERITIS VIRAL 2 0.0001
252 DRUG EFFECT INCOMPLETE 4 0.0001
253 PELVIC PAIN 2 0.0001
254 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
255 UROSEPSIS 1 0.0001
256 NERVE COMPRESSION 1 0.0001
257 IRON DEFICIENCY ANAEMIA 1 0.0001
258 APPENDICITIS 1 0.0001
259 EAR PAIN 2 0.0001
260 THERAPY CHANGE 1 0.0001
261 COMPLICATION OF DEVICE INSERTION 2 0.0001
262 SALIVARY HYPERSECRETION 1 0.0001
263 MOTOR DYSFUNCTION 1 0.0001
264 BODY TEMPERATURE INCREASED 2 0.0001
265 NEUTROPHIL COUNT INCREASED 1 0.0001
266 VENTRICULAR EXTRASYSTOLES 1 0.0001
267 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
268 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
269 INCONTINENCE 1 0.0001
270 RETCHING 2 0.0001
271 HEREDITARY ANGIOEDEMA 1 0.0001
272 PRODUCT DOSE OMISSION 6 0.0001
273 ANAPHYLACTIC REACTION 5 0.0001
274 URINARY RETENTION 3 0.0001
275 OCULAR DISCOMFORT 1 0.0001
276 SPLENOMEGALY 1 0.0001
277 VOMITING 39 0.0001
278 PANIC ATTACK 3 0.0001
279 UNDERDOSE 6 0.0001
280 NO THERAPEUTIC RESPONSE 1 0.0001
281 RESTLESSNESS 3 0.0001
282 INJECTION SITE URTICARIA 2 0.0001
283 INJECTION SITE MASS 3 0.0001
284 HYPERCALCAEMIA 1 0.0001
285 EXTRAPYRAMIDAL DISORDER 2 0.0001
286 INJECTION SITE IRRITATION 1 0.0001
287 MYDRIASIS 1 0.0001
288 THERAPY CESSATION 4 0.0001
289 INFUSION SITE PAIN 1 0.0001
290 RESPIRATORY TRACT INFECTION 2 0.0001
291 SEDATION 2 0.0001
292 EAR INFECTION 2 0.0001
293 INJECTION SITE PRURITUS 5 0.0001
294 QUALITY OF LIFE DECREASED 1 0.0001
295 DRY MOUTH 6 0.0001
296 PRODUCT TASTE ABNORMAL 1 0.0001
297 MOOD ALTERED 2 0.0001
298 WITHDRAWAL SYNDROME 3 0.0001
299 HYPOKINESIA 1 0.0001
300 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
301 PALPITATIONS 8 0.0001
302 AGITATION 5 0.0001
303 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
304 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
305 HYPOAESTHESIA ORAL 1 0.0001
306 VISION BLURRED 9 0.0001
307 INJECTION SITE RASH 2 0.0001
308 LIMB DISCOMFORT 2 0.0001
309 MOOD SWINGS 2 0.0001
310 DRUG DEPENDENCE 10 0.0001
311 MUSCLE TIGHTNESS 1 0.0001
312 CHOLELITHIASIS 2 0.0001
313 FUNGAL INFECTION 2 0.0001
314 NAUSEA 47 0.0001
315 CANDIDA INFECTION 1 0.0001
316 ANGER 2 0.0001
317 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
318 DISTURBANCE IN ATTENTION 3 0.0001
319 RESTLESS LEGS SYNDROME 1 0.0001
320 HYPERHIDROSIS 7 0.0001
321 DYSURIA 2 0.0001
322 URTICARIA 9 0.0001
323 MIDDLE INSOMNIA 1 0.0001
324 BLISTER 3 0.0001
325 HYPOCALCAEMIA 1 0.0001
326 ANXIETY 15 0.0001
327 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
328 INCREASED APPETITE 1 0.0001
329 INJECTION SITE SWELLING 4 0.0001
330 ACUTE RESPIRATORY FAILURE 1 0.0001
331 PRESCRIBED OVERDOSE 1 0.0001
332 CHOKING 1 0.0001
333 MENORRHAGIA 1 0.0001
334 PRESCRIBED UNDERDOSE 1 0.0001
335 FEEDING DISORDER 1 0.0000
336 DYSKINESIA 2 0.0000
337 INJECTION SITE WARMTH 1 0.0000
338 EATING DISORDER 1 0.0000
339 RECTAL HAEMORRHAGE 2 0.0000
340 POOR QUALITY SLEEP 1 0.0000
341 PRURITUS GENERALISED 1 0.0000
342 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
343 PRODUCT DISPENSING ERROR 1 0.0000
344 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
345 INTENTIONAL PRODUCT MISUSE 4 0.0000
346 APPLICATION SITE PAIN 1 0.0000
347 TACHYCARDIA 4 0.0000
348 TRANSAMINASES INCREASED 1 0.0000
349 SNEEZING 1 0.0000
350 THERAPY NON-RESPONDER 2 0.0000
351 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
352 HYPERSENSITIVITY 8 0.0000
353 BURNING SENSATION 3 0.0000
354 SWELLING 4 0.0000
355 SLEEP DISORDER 3 0.0000
356 INJECTION SITE PAIN 13 0.0000
357 TREMOR 7 0.0000
358 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
359 DISEASE RECURRENCE 2 0.0000
360 PRESYNCOPE 1 0.0000
361 UNEVALUABLE EVENT 3 0.0000
362 DEPRESSION 9 0.0000
363 HAEMATEMESIS 1 0.0000
364 CHEST DISCOMFORT 4 0.0000
365 EXPOSURE VIA SKIN CONTACT 1 0.0000
366 HEADACHE 24 0.0000
367 HAEMORRHAGE 4 0.0000
368 ECZEMA 2 0.0000
369 MUCOSAL INFLAMMATION 1 0.0000
370 ANHEDONIA 1 0.0000
371 INJECTION SITE BRUISING 3 0.0000
372 FEELING ABNORMAL 9 0.0000
373 THROAT TIGHTNESS 1 0.0000
374 HAEMATOCHEZIA 2 0.0000
375 DIZZINESS 18 0.0000
376 MEDICATION ERROR 2 0.0000
377 FEELING COLD 1 0.0000
378 NECK PAIN 2 0.0000
379 WOUND 1 0.0000
380 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
381 HYPERSOMNIA 1 0.0000
382 DYSSTASIA 1 0.0000
383 CHILLS 4 0.0000
384 ABDOMINAL PAIN UPPER 7 0.0000
385 INSOMNIA 9 0.0000
386 RENAL INJURY 1 0.0000
387 EMOTIONAL DISTRESS 4 0.0000
388 VERTIGO 2 0.0000
389 DISCOMFORT 2 0.0000
390 BLOOD PRESSURE INCREASED 5 0.0000
391 DRUG ADMINISTRATION ERROR 1 0.0000
392 WEIGHT DECREASED 9 0.0000
393 MOVEMENT DISORDER 1 0.0000
394 NIGHT SWEATS 1 0.0000
395 RHINORRHOEA 2 0.0000
396 DEVICE EXPULSION 2 0.0000
397 AMNESIA 2 0.0000
398 SWELLING FACE 2 0.0000
399 HEART RATE INCREASED 3 0.0000
400 DRUG DOSE OMISSION 5 0.0000
401 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
402 BACK PAIN 7 0.0000
403 EXPIRED PRODUCT ADMINISTERED 1 0.0000
404 PRODUCT QUALITY ISSUE 4 0.0000
405 HEPATIC ENZYME INCREASED 2 0.0000
406 URINARY TRACT INFECTION 5 0.0000
407 SINUSITIS 3 0.0000
408 HYPOXIA 1 0.0000
409 LYMPHADENOPATHY 1 0.0000
410 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
411 PRODUCT ADHESION ISSUE 1 0.0000
412 CEREBRAL HAEMORRHAGE 1 0.0000
413 CRYING 1 0.0000
414 OFF LABEL USE 24 0.0000
415 NASOPHARYNGITIS 5 0.0000
416 INFLUENZA 3 0.0000
417 HYPOAESTHESIA 4 0.0000
418 PRODUCT USE ISSUE 5 0.0000
419 HOT FLUSH 2 0.0000
420 DYSPNOEA 15 0.0000
421 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
422 ABDOMINAL PAIN 6 0.0000
423 DISORIENTATION 1 0.0000
424 DRUG INEFFECTIVE 32 0.0000
425 VISUAL IMPAIRMENT 3 0.0000
426 SKIN EXFOLIATION 2 0.0000
427 OSTEOARTHRITIS 1 0.0000
428 DEVICE DISLOCATION 1 0.0000
429 MUSCULOSKELETAL STIFFNESS 2 0.0000
430 LIVER DISORDER 1 0.0000
431 DEHYDRATION 3 0.0000
432 GASTROINTESTINAL DISORDER 2 0.0000
433 THROAT IRRITATION 1 0.0000
434 FATIGUE 17 0.0000
435 NEPHROLITHIASIS 1 0.0000
436 MUSCLE SPASMS 4 0.0000
437 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
438 CHEST PAIN 4 0.0000
439 COGNITIVE DISORDER 1 0.0000
440 RASH ERYTHEMATOUS 1 0.0000
441 MULTIPLE SCLEROSIS 1 0.0000
442 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
443 PRURITUS 8 0.0000
444 INFECTION 3 0.0000
445 PAIN IN EXTREMITY 6 0.0000
446 DYSPEPSIA 2 0.0000
447 PYREXIA 7 0.0000
448 HAEMOGLOBIN DECREASED 2 0.0000
449 ILLNESS 2 0.0000
450 ABDOMINAL DISTENSION 2 0.0000
451 MUSCULOSKELETAL PAIN 1 0.0000
452 SPEECH DISORDER 1 0.0000
453 DERMATITIS ATOPIC 1 0.0000
454 RASH PRURITIC 1 0.0000
455 CONSTIPATION 4 0.0000
456 PAIN 11 0.0000
457 ASTHMA 2 0.0000
458 MYALGIA 3 0.0000
459 LETHARGY 1 0.0000
460 PRODUCT SUBSTITUTION ISSUE 1 0.0000
461 SEIZURE 2 0.0000
462 COVID-19 3 0.0000
463 BONE PAIN 1 0.0000
464 DIARRHOEA 11 0.0000
465 NASAL CONGESTION 1 0.0000
466 THERAPEUTIC RESPONSE DECREASED 1 0.0000
467 FEELING HOT 1 0.0000
468 INJECTION SITE ERYTHEMA 2 0.0000
469 MALAISE 7 0.0000
470 ASTHENIA 6 0.0000
471 GAIT DISTURBANCE 3 0.0000
472 DEEP VEIN THROMBOSIS 1 0.0000
473 DEVICE DIFFICULT TO USE 1 0.0000
474 SKIN BURNING SENSATION 1 0.0000
475 OVERDOSE 3 0.0000
476 RASH 6 0.0000
477 PRODUCT DOSE OMISSION ISSUE 4 0.0000
478 BRONCHITIS 1 0.0000
479 DYSGEUSIA 1 0.0000
480 EPISTAXIS 1 0.0000
481 HALLUCINATION 1 0.0000
482 ACNE 1 0.0000
483 CONDITION AGGRAVATED 4 0.0000
484 PERIPHERAL SWELLING 2 0.0000
485 DECREASED APPETITE 3 0.0000
486 ARTHRITIS 1 0.0000
487 PARAESTHESIA 2 0.0000
488 DRUG INTERACTION 2 0.0000
489 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
490 CONFUSIONAL STATE 2 0.0000
491 INFLUENZA LIKE ILLNESS 1 0.0000
492 RENAL IMPAIRMENT 1 0.0000
493 DRUG WITHDRAWAL SYNDROME 1 0.0000
494 ADVERSE DRUG REACTION 1 0.0000
495 SUICIDAL IDEATION 1 0.0000
496 OROPHARYNGEAL PAIN 1 0.0000
497 COUGH 3 0.0000
498 CARDIAC DISORDER 1 0.0000
499 DYSPHAGIA 1 0.0000
500 NEUROPATHY PERIPHERAL 1 0.0000
501 ANAEMIA 2 0.0000
502 CONTUSION 1 0.0000
503 FLUSHING 1 0.0000
504 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
505 HYPERTENSION 2 0.0000
506 THROMBOCYTOPENIA 1 0.0000
507 WEIGHT INCREASED 2 0.0000
508 MUSCULAR WEAKNESS 1 0.0000
509 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
510 LOSS OF CONSCIOUSNESS 1 0.0000
511 DRY SKIN 1 0.0000
512 MEMORY IMPAIRMENT 1 0.0000
513 ARTHRALGIA 3 0.0000
514 PNEUMONIA 2 0.0000
515 NO ADVERSE EVENT 1 0.0000
516 BLOOD GLUCOSE INCREASED 1 0.0000
517 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
518 DEATH 4 0.0000